Justin Eyquem, PhD
Assistant Professor, Dept. of Medicine, UCSF
I received my PhD from the University of Paris-Diderot in collaboration with the biotech company Cellectis. During my PhD, I participated to the development of gene editing tools such as Meganuclease or TALEN in primary human cells and notably identified genomic location for safe integration of therapeutic genes. In 2014, I joined Michel Sadelain's lab at the MSKCC and used CRISPR/Cas9 to engineer CAR T cells. I showed how targeting CAR transgene into specific loci enhance T cell efficacy, advance CAR immuno-biology and facilitate T cell manufacturing. Early 2019, I received the Parker Fellow Award and opened my lab in the department of Microbiology and Immunology at UCSF where I am developing a gene editing platform to enhance CAR T and NK cell functions in hematological and solid tumors.
University of Bordeaux, France, B.S., 2006, Biology/Chemistry
AgroParisTech, France, Master, 2010, Bioengineering
University of Paris VII, France, Master, 2010, Genetics
University of Paris VII, France, Ph.D., 2014, Immunology - Molecular Biology
Memorial Sloan-Kettering Cancer Center, Postdoctoral, 2019, Immunotherapy